-
1
-
-
74549128529
-
Epidemiology of hepatitis B and C viruses: A global overview
-
Te, H. S.; Jensen, D. M. Epidemiology of hepatitis B and C viruses: a global overview Clin. Liver Dis. 2010, 14, 1-21
-
(2010)
Clin. Liver Dis.
, vol.14
, pp. 1-21
-
-
Te, H.S.1
Jensen, D.M.2
-
2
-
-
23944506014
-
Global epidemiology of hepatitis C virus infection
-
Shepard, C. W.; Finelli, L.; Alter, M. J. Global epidemiology of hepatitis C virus infection Lancet Infect. Dis. 2005, 5, 558-567
-
(2005)
Lancet Infect. Dis.
, vol.5
, pp. 558-567
-
-
Shepard, C.W.1
Finelli, L.2
Alter, M.J.3
-
3
-
-
84860287080
-
Epidemiology of viral hepatitis and hepatocellular carcinoma
-
El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 2012, 142, 1264-1273
-
(2012)
Gastroenterology
, vol.142
, pp. 1264-1273
-
-
El-Serag, H.B.1
-
4
-
-
33748114343
-
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
-
Perz, J. F.; Armstrong, G. L.; Farrington, L. A.; Hutin, Y. J. F.; Bell, B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J. Hepatol. 2006, 45, 529-538
-
(2006)
J. Hepatol.
, vol.45
, pp. 529-538
-
-
Perz, J.F.1
Armstrong, G.L.2
Farrington, L.A.3
Hutin, Y.J.F.4
Bell, B.P.5
-
5
-
-
80755159054
-
Discovery and development of telaprevir: An NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
-
Kwong, A. D.; Kauffman, R. S.; Hurter, P.; Mueller, P. Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus Nature Biotechnol. 2011, 29, 993-1003
-
(2011)
Nature Biotechnol.
, vol.29
, pp. 993-1003
-
-
Kwong, A.D.1
Kauffman, R.S.2
Hurter, P.3
Mueller, P.4
-
6
-
-
84860526352
-
Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections
-
Venkatraman, S. Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections Trends Pharmacol. Sci. 2012, 33, 289-294
-
(2012)
Trends Pharmacol. Sci.
, vol.33
, pp. 289-294
-
-
Venkatraman, S.1
-
7
-
-
79952907820
-
The journey to the discovery of boceprevir: An NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C
-
Chen, K. X.; Njoroge, F. G. The journey to the discovery of boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C Prog. Med. Chem. 2010, 49, 1-36
-
(2010)
Prog. Med. Chem.
, vol.49
, pp. 1-36
-
-
Chen, K.X.1
Njoroge, F.G.2
-
8
-
-
84856371566
-
New Merck and Vertex drugs raise standard of care in hepatitis C
-
Sheridan, C. W. New Merck and Vertex drugs raise standard of care in hepatitis C Nature Biotechnol. 2011, 29, 553-554
-
(2011)
Nature Biotechnol.
, vol.29
, pp. 553-554
-
-
Sheridan, C.W.1
-
9
-
-
0037517079
-
Side effects of therapy for chronic hepatitis C
-
Fried, M. W.; Russo, M. W.; Fried, M. W. Side effects of therapy for chronic hepatitis C Gastroenterology 2003, 124, 1711-1719
-
(2003)
Gastroenterology
, vol.124
, pp. 1711-1719
-
-
Fried, M.W.1
Russo, M.W.2
Fried, M.W.3
-
10
-
-
33747797031
-
Treating viral hepatitis C: Efficacy, side effects, and complications
-
Manns, M. P.; Wedemeyer, H.; Cornberg, M. Treating viral hepatitis C: efficacy, side effects, and complications Gut 2006, 55, 1350-1359
-
(2006)
Gut
, vol.55
, pp. 1350-1359
-
-
Manns, M.P.1
Wedemeyer, H.2
Cornberg, M.3
-
11
-
-
0034484070
-
Genome of human hepatitis C virus (HCV): Gene organization, sequence diversity, and variation
-
Kato, N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation Microb. Comp. Genomics 2000, 5 (3) 129-151
-
(2000)
Microb. Comp. Genomics
, vol.5
, Issue.3
, pp. 129-151
-
-
Kato, N.1
-
12
-
-
34250681358
-
Hepatitis C virus proteins
-
Dubuisson, J. Hepatitis C virus proteins World J. Gastroenterol. 2007, 13 (17) 2406-2415
-
(2007)
World J. Gastroenterol.
, vol.13
, Issue.17
, pp. 2406-2415
-
-
Dubuisson, J.1
-
13
-
-
84855209804
-
Direct acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow
-
Asselah, T.; Marcellin, P. Direct acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow Liver Int. 2012, 32 (Suppl 1) 88-102
-
(2012)
Liver Int.
, vol.32
, Issue.SUPPL. 1
, pp. 88-102
-
-
Asselah, T.1
Marcellin, P.2
-
14
-
-
84860322902
-
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
-
Welsch, C.; Jesudian, A.; Zeuzem, S.; Jacobson, I. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives Gut Liver 2012, 61, i36-i46
-
(2012)
Gut Liver
, vol.61
-
-
Welsch, C.1
Jesudian, A.2
Zeuzem, S.3
Jacobson, I.4
-
15
-
-
80555127355
-
Drugs in development for chronic hepatitis C: A promising future
-
Pockros, P. J. Drugs in development for chronic hepatitis C: a promising future Expert Opin. Biol. Ther. 2011, 11, 1611-1622
-
(2011)
Expert Opin. Biol. Ther.
, vol.11
, pp. 1611-1622
-
-
Pockros, P.J.1
-
16
-
-
84855921173
-
Novel therapies for hepatitis C: Insights from the structure of the virus
-
Fusco, D. N.; Chung, R. T. Novel therapies for hepatitis C: insights from the structure of the virus Annu. Rev. Med. 2012, 63, 373-387
-
(2012)
Annu. Rev. Med.
, vol.63
, pp. 373-387
-
-
Fusco, D.N.1
Chung, R.T.2
-
17
-
-
77952268322
-
Development of novel therapies for hepatitis C
-
Lemon, S. M.; McKeating, J. A.; Pietschmann, T.; Frick, D. N.; Glenn, J. S.; Tellinghuisen, T. L.; Symons, J.; Furman, P. A. Development of novel therapies for hepatitis C Antiviral Res. 2010, 86, 79-92
-
(2010)
Antiviral Res.
, vol.86
, pp. 79-92
-
-
Lemon, S.M.1
McKeating, J.A.2
Pietschmann, T.3
Frick, D.N.4
Glenn, J.S.5
Tellinghuisen, T.L.6
Symons, J.7
Furman, P.A.8
-
18
-
-
84939257725
-
Recent progress in the development of HCV protease inhibitors
-
Mani, N.; Rao, B. G.; Kieffer, T. L.; Kwong, A. D. Recent progress in the development of HCV protease inhibitors Methods Principals Med. Chem. 2011, 50, 307-328
-
(2011)
Methods Principals Med. Chem.
, vol.50
, pp. 307-328
-
-
Mani, N.1
Rao, B.G.2
Kieffer, T.L.3
Kwong, A.D.4
-
19
-
-
78650021698
-
Recent advances in hepatitis C virus treatment: Review of HCV protease inhibitor clinical trials
-
Chary, A.; Holodniy, M. Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials Rev. Recent Clin. Trials 2010, 5, 158-173
-
(2010)
Rev. Recent Clin. Trials
, vol.5
, pp. 158-173
-
-
Chary, A.1
Holodniy, M.2
-
20
-
-
81855220325
-
The therapeutic approaches for hepatitis C virus: Protease inhibitors and polymerase inhibitors
-
Kwo, P. Y.; Vinayek, R. The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors Gut 2011, 5, 406-417
-
(2011)
Gut
, vol.5
, pp. 406-417
-
-
Kwo, P.Y.1
Vinayek, R.2
-
21
-
-
84952988807
-
Daclatasvir dihydrochloride: Treatment of hepatitis C virus HCV NS5A inhibitor
-
Reviriego, C. Daclatasvir dihydrochloride: treatment of hepatitis C virus HCV NS5A inhibitor Drugs Future 2011, 36, 735-739
-
(2011)
Drugs Future
, vol.36
, pp. 735-739
-
-
Reviriego, C.1
-
22
-
-
81855220325
-
The therapeutic approaches for hepatitis C virus: Protease inhibitors and polymerase inhibitors
-
Kwo, P. Y.; Vinayek, R. The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors Gut 2011, 5, 406-417
-
(2011)
Gut
, vol.5
, pp. 406-417
-
-
Kwo, P.Y.1
Vinayek, R.2
-
23
-
-
84858722318
-
Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase
-
Sofia, M. J.; Chang, W.; Furman, P. A.; Mosley, R. T.; Ross, B. S. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase J. Med. Chem. 2012, 55, 2481-2531
-
(2012)
J. Med. Chem.
, vol.55
, pp. 2481-2531
-
-
Sofia, M.J.1
Chang, W.2
Furman, P.A.3
Mosley, R.T.4
Ross, B.S.5
-
24
-
-
77953445361
-
Non-nucleoside inhibitors of hepatitis C virus polymerase: Current progress and future challenges
-
Li, H.; Shi, S. T. Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges Future Med. Chem. 2010, 2, 121-141
-
(2010)
Future Med. Chem.
, vol.2
, pp. 121-141
-
-
Li, H.1
Shi, S.T.2
-
25
-
-
77954628601
-
HCV NS5B polymerase inhibitors
-
Watkins, W. J.; Ray, A. S.; Chong, L. S. HCV NS5B polymerase inhibitors Curr. Opin. Drug Discovery Dev. 2010, 13, 441-465
-
(2010)
Curr. Opin. Drug Discovery Dev.
, vol.13
, pp. 441-465
-
-
Watkins, W.J.1
Ray, A.S.2
Chong, L.S.3
-
26
-
-
77953013128
-
Rapid emergence of protease inhibitor resistance in hepatitis C virus
-
Rong, L.; Dahari, H.; Ribeiro, R. M.; Perelson, A. S. Rapid emergence of protease inhibitor resistance in hepatitis C virus Sci. Transl. Med. 2010, 2, 1-9
-
(2010)
Sci. Transl. Med.
, vol.2
, pp. 1-9
-
-
Rong, L.1
Dahari, H.2
Ribeiro, R.M.3
Perelson, A.S.4
-
27
-
-
84876246624
-
Persistence of variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir
-
Wang, C.; Sun, J. H.; O'Boyle, D. R.; Nower, P.; Valera, L.; Roberts, S.; Fridell, R. A.; Gao, M. Persistence of variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir Antimicrob. Agents Chemother. 2013, 57 (5) 2054-2065
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, Issue.5
, pp. 2054-2065
-
-
Wang, C.1
Sun, J.H.2
O'Boyle, D.R.3
Nower, P.4
Valera, L.5
Roberts, S.6
Fridell, R.A.7
Gao, M.8
-
28
-
-
83555174694
-
In vitro selection and characterization of HCV replicons resistent to multiple non-nucleoside polymerase inhibitors
-
Delang, L.; Vliegen, I.; Leyssen, P.; Neyts, J. In vitro selection and characterization of HCV replicons resistent to multiple non-nucleoside polymerase inhibitors J. Hepatol. 2012, 56 (1) 41-48
-
(2012)
J. Hepatol.
, vol.56
, Issue.1
, pp. 41-48
-
-
Delang, L.1
Vliegen, I.2
Leyssen, P.3
Neyts, J.4
-
29
-
-
77649175920
-
Hepatitis C virus nonstructural protein 4B: A journey into unexplored territory
-
Gouttenoire, J.; Roingeard, P.; Penin, F.; Moradpour, D. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory Rev. Med. Virol. 2010, 20 (2) 117-129
-
(2010)
Rev. Med. Virol.
, vol.20
, Issue.2
, pp. 117-129
-
-
Gouttenoire, J.1
Roingeard, P.2
Penin, F.3
Moradpour, D.4
-
30
-
-
80054117912
-
Hepatitis C virus - Progress towards inhibiting the nonenzymatic viral proteins
-
Meanwell, N. A.; Belema, M. Hepatitis C virus-Progress towards inhibiting the nonenzymatic viral proteins Annu. Rep. Med. Chem. 2011, 46, 268-270
-
(2011)
Annu. Rep. Med. Chem.
, vol.46
, pp. 268-270
-
-
Meanwell, N.A.1
Belema, M.2
-
31
-
-
77953535846
-
A small molecule inhibits HCV replication and alters NS4B's subcellular distribution
-
Brysona, P. D.; Choa, N. J.; Einava, S.; Leea, C.; Taid, V.; Bechteld, J.; Sivarajad, M.; Robertsd, C.; Schmitzd, U.; Glenn, J. S. A small molecule inhibits HCV replication and alters NS4B's subcellular distribution Antiviral Res. 2010, 87, 1-8
-
(2010)
Antiviral Res.
, vol.87
, pp. 1-8
-
-
Brysona, P.D.1
Choa, N.J.2
Einava, S.3
Leea, C.4
Taid, V.5
Bechteld, J.6
Sivarajad, M.7
Robertsd, C.8
Schmitzd, U.9
Glenn, J.S.10
-
32
-
-
84863856281
-
Imidazo[1,2-a]pyridines that directly interact with hepatitis C NS4B: Initial preclinical characterization
-
Shotwell, J. B.; Baskaran, S.; Chong, P.; Creech, K. L.; Crosby, R. M.; Dicks, H.; Fang, J.; Garrido, D.; Mathis, A.; Maung, J.; Parks, D. J.; Pouliot, J. J.; Price, D. J.; Rai, R.; Seal, J. W.; Schmitz, U.; Tai, V. W. F.; Thomson, M.; Xie, M.; Xiong, J. J.; Peat, A. J. Imidazo[1,2- a ]pyridines that directly interact with hepatitis C NS4B: initial preclinical characterization ACS Med. Chem. Lett. 2012, 3, 565-569
-
(2012)
ACS Med. Chem. Lett.
, vol.3
, pp. 565-569
-
-
Shotwell, J.B.1
Baskaran, S.2
Chong, P.3
Creech, K.L.4
Crosby, R.M.5
Dicks, H.6
Fang, J.7
Garrido, D.8
Mathis, A.9
Maung, J.10
Parks, D.J.11
Pouliot, J.J.12
Price, D.J.13
Rai, R.14
Seal, J.W.15
Schmitz, U.16
Tai, V.W.F.17
Thomson, M.18
Xie, M.19
Xiong, J.J.20
Peat, A.J.21
more..
-
33
-
-
84896296094
-
Hepatitis C replication inhibitors that target the viral NS4B protein
-
10.1021/jm400125h
-
Miller, J. F.; Chong, P. Y.; Shotwell, J. B.; Catalano, J. G.; Tai, V. W.; Fang, J.; Banka, A.; Roberts, C. D.; Youngman, M.; Zhang, H.; Xiong, Z.; Mathis, A.; Pouliot, J. J.; Hamatake, R. K.; Price, D. J.; Seal, J. W.; Stroup, L. L.; Creech, K. L.; Carballo, L. H.; Todd, D.; Spaltenstein, A.; Furst, S.; Hong, Z.; Peat, A. J. Hepatitis C replication inhibitors that target the viral NS4B protein. J. Med. Chem. 2013, 10.1021/jm400125h.
-
(2013)
J. Med. Chem.
-
-
Miller, J.F.1
Chong, P.Y.2
Shotwell, J.B.3
Catalano, J.G.4
Tai, V.W.5
Fang, J.6
Banka, A.7
Roberts, C.D.8
Youngman, M.9
Zhang, H.10
Xiong, Z.11
Mathis, A.12
Pouliot, J.J.13
Hamatake, R.K.14
Price, D.J.15
Seal, J.W.16
Stroup, L.L.17
Creech, K.L.18
Carballo, L.H.19
Todd, D.20
Spaltenstein, A.21
Furst, S.22
Hong, Z.23
Peat, A.J.24
more..
-
34
-
-
84879015904
-
Identification of PTC725: An orally bioavailable small molecule that selectively targets the hepatitis C virus NS4B protein
-
Gu, Z.; Graci, J. D.; Lahser, F. C.; Breslin, J.; Jung, S. P.; Crona, J. H.; McMonagle, P.; Xia, E.; Liu, S.; Karp, G.; Zhu, J.; Huang, S.; Nomeir, A.; Weetall, M.; Almstead, N. G.; Peltz, S. W.; Tong, X.; Ralston, R.; Colacino, J. M. Identification of PTC725: an orally bioavailable small molecule that selectively targets the hepatitis C virus NS4B protein Antimicrob. Agents Chemother. 2013, 57 (5) 2054-2065
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, Issue.5
, pp. 2054-2065
-
-
Gu, Z.1
Graci, J.D.2
Lahser, F.C.3
Breslin, J.4
Jung, S.P.5
Crona, J.H.6
McMonagle, P.7
Xia, E.8
Liu, S.9
Karp, G.10
Zhu, J.11
Huang, S.12
Nomeir, A.13
Weetall, M.14
Almstead, N.G.15
Peltz, S.W.16
Tong, X.17
Ralston, R.18
Colacino, J.M.19
-
35
-
-
84878839250
-
Discovery of novel HCV inhibitors: Synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targetting hepatitis C virus NS4B
-
Zhang, X.; Zhang, N.; Chen, G.; Turpoff, A.; Ren, H.; Takasugi, J.; Morrill, C.; Zhu, J.; Li, C.; Lennox, W.; Paget, S.; Liu, Y.; Almstead, N.; George Njoroge, F.; Gu, Z.; Komatsu, T.; Clausen, V.; Espiritu, C.; Graci, J.; Colacino, J.; Lahser, F.; Risher, N.; Weetall, M.; Nomeir, A.; Karp, G. M. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targetting hepatitis C virus NS4B Bioorg. Med. Chem. Lett. 2013, 23 (13) 3947-3953
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, Issue.13
, pp. 3947-3953
-
-
Zhang, X.1
Zhang, N.2
Chen, G.3
Turpoff, A.4
Ren, H.5
Takasugi, J.6
Morrill, C.7
Zhu, J.8
Li, C.9
Lennox, W.10
Paget, S.11
Liu, Y.12
Almstead, N.13
George Njoroge, F.14
Gu, Z.15
Komatsu, T.16
Clausen, V.17
Espiritu, C.18
Graci, J.19
Colacino, J.20
Lahser, F.21
Risher, N.22
Weetall, M.23
Nomeir, A.24
Karp, G.M.25
more..
-
36
-
-
84878826680
-
1-(indol-2-yl)phenyl)-sulfonamides as novel inhibitors of HCV replication
-
1-(indol-2-yl)phenyl)-sulfonamides as novel inhibitors of HCV replication Bioorg. Med. Chem. Lett. 2013, 23 (13) 3942-3946
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, Issue.13
, pp. 3942-3946
-
-
Chen, G.1
Ren, H.2
Turpoff, A.3
Arefolov, A.4
Wilde, R.5
Takasugi, J.6
Khan, A.7
Almstead, N.8
Gu, Z.9
Komatsu, T.10
Freund, C.11
Breslin, J.12
Colacino, J.13
Hedrick, J.14
Weetall, M.15
Karp, G.M.16
-
37
-
-
0010658836
-
Synthese von 3,6-disubstituierten 2-oxopiperazinen
-
Masaki, V. M.; Ohta, M. Synthese von 3,6-disubstituierten 2-oxopiperazinen Bull. Chem. Soc. Jpn. 1963, 36 (8) 922-925
-
(1963)
Bull. Chem. Soc. Jpn.
, vol.36
, Issue.8
, pp. 922-925
-
-
Masaki, V.M.1
Ohta, M.2
-
38
-
-
0030840273
-
A new synthesis of α-arylglycines from aryl boronic acids
-
Petasis, N. A.; Goodman, A.; Zavialov, T. A new synthesis of α-arylglycines from aryl boronic acids Tetrahedron 1997, 53 (48) 16463-16470
-
(1997)
Tetrahedron
, vol.53
, Issue.48
, pp. 16463-16470
-
-
Petasis, N.A.1
Goodman, A.2
Zavialov, T.3
-
39
-
-
77951002240
-
A straightforward three-component synthesis of α-amino esters containing a phenylalanine or a phenylglycine scaffold
-
Haurena, C.; Le Gall, E.; Sengmany, S.; Martens, T.; Troupel, M. A straightforward three-component synthesis of α-amino esters containing a phenylalanine or a phenylglycine scaffold J. Org. Chem. 2010, 75 (8) 2645-2650
-
(2010)
J. Org. Chem.
, vol.75
, Issue.8
, pp. 2645-2650
-
-
Haurena, C.1
Le Gall, E.2
Sengmany, S.3
Martens, T.4
Troupel, M.5
-
40
-
-
77957913871
-
1-α- fluoro-20-β- C -methyl-uridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus
-
1-α-fluoro-20- β- C -methyl-uridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus J. Med. Chem. 2010, 53, 7202-7218
-
(2010)
J. Med. Chem.
, vol.53
, pp. 7202-7218
-
-
Sofia, M.J.1
Bao, D.2
Chang, W.3
Du, J.4
Nagarathnam, D.5
Rachakonda, S.6
Reddy, P.G.7
Ross, B.S.8
Wang, P.9
Zhang, H.-R.10
Bansal, S.11
Espiritu, C.12
Keilman, M.13
Lam, A.M.14
Steuer, H.M.M.15
Niu, C.16
Otto, M.J.17
Furman, P.A.18
-
41
-
-
84896303364
-
-
U.S. Patent US20120202794A1, September 8
-
Sofia, M. J.; Kakarla, R.; Liu, J.; Naduthambi, D.; Mosley, R.; Steuer, H. M. Preparation of piperazine derivatives and their uses to treat viral infections, including hepatitis C. U.S. Patent US20120202794A1, September 8, 2012.
-
(2012)
Preparation of Piperazine Derivatives and Their Uses to Treat Viral Infections, Including Hepatitis C
-
-
Sofia, M.J.1
Kakarla, R.2
Liu, J.3
Naduthambi, D.4
Mosley, R.5
Steuer, H.M.6
-
42
-
-
84896303364
-
-
WO 2012103113A1, February 8
-
Sofia, M. J.; Kakarla, R.; Liu, J.; Naduthambi, D.; Mosley, R.; Steuer, H. M. Preparation of pyrazine and imidazolidine derivatives and their uses to treat viral infections, including hepatitis C. WO 2012103113A1, February 8, 2012.
-
(2012)
Preparation of Pyrazine and Imidazolidine Derivatives and Their Uses to Treat Viral Infections, Including Hepatitis C
-
-
Sofia, M.J.1
Kakarla, R.2
Liu, J.3
Naduthambi, D.4
Mosley, R.5
Steuer, H.M.6
|